AARDA and 50+ Patient Groups Send Letter to Key Members of Congress on Drug Pricing Priorities for Autoimmune Patients
August 3, 2021

American Autoimmune Related Diseases Association Releases Statement on EUA for COVID-19 Booster Doses

American Autoimmune Related Diseases Association Releases Statement on EUA for COVID-19 Booster Doses

DETROIT – The Food and Drug Administration (FDA), expanded the emergency use authorizations (EUA) for the Pfizer-BioNTech and Moderna vaccines to allow certain people with compromised immune systems to receive a third “booster” dose on Thursday, August 12, 2021. Given that studies have shown people with weakened immune systems are more likely to have a serious case of COVID-19 if contracted, coupled with the rise of the Delta variant, AARDA recommends that any person living with an autoimmune disease contact their physician immediately to discuss an additional booster. Read the full statement from the CDC here.

# # #

About AARDA
American Autoimmune Related Diseases Association (AARDA) is the nation’s only nonprofit organization dedicated to bringing a national focus to autoimmunity as a category of disease and a major women’s health issue and promoting a collaborative research effort in order to find better treatments and a cure for all autoimmune diseases.

For upcoming AARDA events visit Events Calendar at www.aarda.org. For more information, visit www.aarda.org. Follow us on social media: Facebook, Twitter, LinkedIn, Instagram, and YouTube.

 

Leave a Reply

Your email address will not be published. Required fields are marked *